On the public citation graph

Cardiotoxicity of Trastuzumab in Clinical Practice

https://doi.org/10.1056/nejmc070065
0 signed · 85 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1016/s0140-6736(07)60028-2openalex-snapshot
2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial
inferredcites →https://doi.org/10.1056/nejmoa052122openalex-snapshot
Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
inferredcites →https://doi.org/10.1056/nejmoa052306openalex-snapshot
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
inferredcites →https://doi.org/10.1200/jco.20.5.1215openalex-snapshot
Cardiac Dysfunction in the Trastuzumab Clinical Trials Experience

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4116273openalex-extracted
Usefulness of Cardiac Magnetic Resonance for Early Detection of Cancer Therapeutics-Related Cardiac Dysfunction in Breast Cancer Patients
inferred← citeshttps://doi.org/10.1002/9780470660379.ch7openalex-snapshot
Cardiovascular Toxicity of Antitumor Drugs: Translating Molecular Mechanisms into Clinical Facts
inferred← citeshttps://doi.org/10.1002/pds.1482openalex-snapshot
Current awareness: Pharmacoepidemiology and drug safety
inferred← citeshttps://doi.org/10.1007/978-0-387-77976-8_5openalex-snapshot
Monoclonal Antibodies as Therapeutic Agents
inferred← citeshttps://doi.org/10.1007/978-3-030-58677-5_13openalex-snapshot
Cardio-Oncology: Preventing Broken Hearts in Women with Breast Cancer
inferred← citeshttps://doi.org/10.1007/978-3-319-30273-7_5openalex-snapshot
Monoclonal Antibodies as Therapeutic Agents
inferred← citeshttps://doi.org/10.1007/978-3-540-75863-1_12openalex-snapshot
Heart, Coronary Arteries, Aorta and Great Vessels, Arteries and Veins, Microcirculation
inferred← citeshttps://doi.org/10.1007/s00063-009-1005-yopenalex-snapshot
Antikörpertherapie in der Hämatologie und Onkologie – Teil 2*
inferred← citeshttps://doi.org/10.1007/s10549-007-9877-0openalex-snapshot
Cardiotoxicity and anthracyclines
inferred← citeshttps://doi.org/10.1007/s10549-016-3823-yopenalex-snapshot
Long-term cardiovascular outcomes and overall survival of early-stage breast cancer patients with early discontinuation of trastuzumab: a population-based study
inferred← citeshttps://doi.org/10.1007/s10549-018-5058-6openalex-snapshot
A real-world study of cardiac events in > 3700 patients with HER2-positive early breast cancer treated with trastuzumab: final analysis of the OHERA study
inferred← citeshttps://doi.org/10.1007/s10549-020-05614-5openalex-snapshot
Comparison of outcomes in a population-based cohort of metastatic breast cancer patients receiving anti-HER2 therapy with clinical trial outcomes
inferred← citeshttps://doi.org/10.1007/s11523-009-0112-2openalex-snapshot
Cardiac toxicity with anti-HER-2 therapies-what have we learned so far?
inferred← citeshttps://doi.org/10.1007/s12015-017-9736-2openalex-snapshot
High-Content Assessment of Cardiac Function Using Heart-on-a-Chip Devices as Drug Screening Model
inferred← citeshttps://doi.org/10.1007/s12032-010-9717-7openalex-snapshot
Cardiac risk associated with the receipt of anthracycline and trastuzumab in a large nationwide cohort of older women with breast cancer, 1998–2005
inferred← citeshttps://doi.org/10.1016/b978-0-12-802509-3.00039-xopenalex-snapshot
Cardiac Monitoring During Clinical Trials
inferred← citeshttps://doi.org/10.1016/j.amcp.2018.03.009openalex-snapshot
Les cardiomyopathies toxiques liées aux chimiothérapies
inferred← citeshttps://doi.org/10.1016/j.cardfail.2011.10.015openalex-snapshot
Trastuzumab Adjuvant Chemotherapy and Cardiotoxicity in Real-World Women With Breast Cancer
inferred← citeshttps://doi.org/10.1016/j.cjca.2016.06.002openalex-snapshot
The Cardioprotective Role of N-Acetyl Cysteine Amide in the Prevention of Doxorubicin and Trastuzumab–Mediated Cardiac Dysfunction
inferred← citeshttps://doi.org/10.1016/j.cjca.2018.11.028openalex-snapshot
Cardioprotective Effect of Statins in Patients With HER2-Positive Breast Cancer Receiving Trastuzumab Therapy
inferred← citeshttps://doi.org/10.1016/j.cjco.2024.03.009openalex-snapshot
Efficacy of Flaxseed Compared to ACE Inhibition in Treating Anthracycline- and Trastuzumab-Induced Cardiotoxicity
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2016.04.015openalex-snapshot
Human epidermal growth factor antagonists and cardiotoxicity—A short review of the problem and preventative measures
inferred← citeshttps://doi.org/10.1016/j.ijcard.2013.01.011openalex-snapshot
Successful use of Trastuzumab following cardiac resynchronisation therapy
inferred← citeshttps://doi.org/10.1016/j.ijcard.2022.09.025openalex-snapshot
Usefulness of cardiac magnetic resonance for early detection of cancer therapeutics-related cardiac dysfunction in breast cancer patients
inferred← citeshttps://doi.org/10.1016/j.pcad.2010.05.006openalex-snapshot
Cardiac Toxicity From Systemic Cancer Therapy: A Comprehensive Review
inferred← citeshttps://doi.org/10.1016/j.phrs.2013.10.001openalex-snapshot
Heart remodeling induced by adjuvant trastuzumab-containing chemotherapy for breast cancer overexpressing human epidermal growth factor receptor type 2: A prospective study
inferred← citeshttps://doi.org/10.1016/s0716-8640(12)70380-2openalex-snapshot
Prevención de la cardiotoxicidad en pacientes que reciben quimioterapia
inferred← citeshttps://doi.org/10.1016/s1130-6343(09)72165-8openalex-snapshot
Cardiotoxicidad asociada a trastuzumab en la práctica clínica asistencial
inferred← citeshttps://doi.org/10.1016/s2173-5085(09)70085-1openalex-snapshot
Cardiotoxicity associated with trastuzumab in normal clinical practice
inferred← citeshttps://doi.org/10.1038/s41598-017-12048-5openalex-snapshot
Kinase inhibitor screening using artificial neural networks and engineered cardiac biowires
inferred← citeshttps://doi.org/10.1093/ehjcvp/pvab016openalex-snapshot
Cardiac and cardiometabolic phenotyping of trastuzumab-mediated cardiotoxicity: a secondary analysis of the MANTICORE trial
inferred← citeshttps://doi.org/10.1093/jnci/djv301openalex-snapshot
The Temporal Risk of Heart Failure Associated With Adjuvant Trastuzumab in Breast Cancer Patients: A Population Study
inferred← citeshttps://doi.org/10.1097/cco.0b013e32833ab6f1openalex-snapshot
Insights into cardiovascular side-effects of modern anticancer therapeutics
inferred← citeshttps://doi.org/10.1111/j.1445-5994.2011.02604.xopenalex-snapshot
Positive spillover effects of prescribing requirements: increased cardiac testing in patients treated with trastuzumab for HER2+ metastatic breast cancer
inferred← citeshttps://doi.org/10.1111/j.1524-4741.2011.01101.xopenalex-snapshot
Lack of Uniformity in Cardiac Assessment during Trastuzumab Therapy
inferred← citeshttps://doi.org/10.1111/tbj.13672openalex-snapshot
Trastuzumab‐induced cardiac toxicity: Is serial assessment of left ventricular ejection fraction during treatment necessary?
inferred← citeshttps://doi.org/10.1136/bmj.a421openalex-snapshot
Management of breast cancer--Part I
inferred← citeshttps://doi.org/10.1136/bmj.a540openalex-snapshot
Management of breast cancer--Part II
inferred← citeshttps://doi.org/10.1139/cjpp-2013-0470openalex-snapshot
Catching broken hearts: pre-clinical detection of doxorubicin and trastuzumab mediated cardiac dysfunction in the breast cancer setting
inferred← citeshttps://doi.org/10.1139/cjpp-2023-0358openalex-snapshot
Preventing broken hearts in women with breast cancer: a concise review on chemotherapy-mediated cardiotoxicity
inferred← citeshttps://doi.org/10.1155/2012/743193openalex-snapshot
The HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in Therapy
inferred← citeshttps://doi.org/10.1158/1078-0432.ccr-09-0628openalex-snapshot
Adjuvant Trastuzumab Induces Ventricular Remodeling Despite Aerobic Exercise Training
inferred← citeshttps://doi.org/10.1159/000499383openalex-snapshot
Treatment-Induced Cardiotoxicity in Breast Cancer: A Review of the Interest of Practicing a Physical Activity
inferred← citeshttps://doi.org/10.1161/circulationaha.108.776831openalex-snapshot
Mechanisms of Cardiac Dysfunction Associated With Tyrosine Kinase Inhibitor Cancer Therapeutics
inferred← citeshttps://doi.org/10.1161/circulationaha.112.100560openalex-snapshot
Cancer Therapy–Induced Cardiac Toxicity in Early Breast Cancer
inferred← citeshttps://doi.org/10.1164/rccm.200811-1682ocopenalex-snapshot
Role of Epidermal Growth Factor Inhibition in Experimental Pulmonary Hypertension
inferred← citeshttps://doi.org/10.1177/030089160809400527openalex-snapshot
Irreversible Cardiotoxicity after Adjuvant Treatment with Trastuzumab in a Case of Breast Cancer
inferred← citeshttps://doi.org/10.1179/joc.2011.23.1.32openalex-snapshot
Trastuzumab and Vinorelbine in Early Stages of HER2-Positive Breast Cancer
inferred← citeshttps://doi.org/10.1186/1471-2407-11-318openalex-snapshot
Rationale and design of the Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research Trial (MANTICORE 101 - Breast): a randomized, placebo-controlled trial to determine if conventional heart failure pharmacotherapy can prevent trastuzumab-mediated left ventricular remodeling…
inferred← citeshttps://doi.org/10.1186/1756-0500-6-339openalex-snapshot
Cardiac safety of the adjuvant Trastuzumab in a Moroccan population: observational monocentric study of about 100 patients
inferred← citeshttps://doi.org/10.1186/s12885-016-2761-8openalex-snapshot
Rationale and design of the multidisciplinary team IntervenTion in cArdio-oNcology study (TITAN)
inferred← citeshttps://doi.org/10.1186/s12947-015-0011-xopenalex-snapshot
The role of renin angiotensin system antagonists in the prevention of doxorubicin and trastuzumab induced cardiotoxicity
inferred← citeshttps://doi.org/10.1186/s12947-020-00210-5openalex-snapshot
Left atrial longitudinal strain as a predictor of Cancer therapeutics-related cardiac dysfunction in patients with breast Cancer
inferred← citeshttps://doi.org/10.1200/jco.2007.15.5044openalex-snapshot
Trastuzumab-Related Cardiotoxicity in the Herceptin Adjuvant Trial
inferred← citeshttps://doi.org/10.1200/jco.2012.44.0891openalex-snapshot
Running on Empty: Cardiovascular Reserve Capacity and Late Effects of Therapy in Cancer Survivorship
inferred← citeshttps://doi.org/10.1200/jco.2013.48.7884openalex-snapshot
Trastuzumab-Related Cardiotoxicity Among Older Patients With Breast Cancer
inferred← citeshttps://doi.org/10.1200/jco.2014.58.9465openalex-snapshot
Cardiac Monitoring During Adjuvant Trastuzumab-Based Chemotherapy Among Older Patients With Breast Cancer
inferred← citeshttps://doi.org/10.1200/jco.2015.61.8983openalex-snapshot
Change in Pattern of HER2 Fluorescent in Situ Hybridization (FISH) Results in Breast Cancers Submitted for FISH Testing: Experience of a Reference Laboratory Using US Food and Drug Administration Criteria and American Society of Clinical Oncology and College of American Pathologists Guidelines
inferred← citeshttps://doi.org/10.1515/fco-2016-0007openalex-snapshot
Cardiotoxicity of the adjuvant trastuzumab in a Saudi population: clinical experience of a single institution
inferred← citeshttps://doi.org/10.1517/14740338.2011.589834openalex-snapshot
Anthracycline cardiotoxicity
inferred← citeshttps://doi.org/10.1536/ihj.25-649openalex-snapshot
Effective Transcatheter Mitral Valve Repair for Reverse Remodeling in Cancer Therapy-Related Cardiac Dysfunction
inferred← citeshttps://doi.org/10.1634/theoncologist.2008-0137openalex-snapshot
Minimizing Cardiotoxicity While Optimizing Treatment Efficacy with Trastuzumab: Review and Expert Recommendations
inferred← citeshttps://doi.org/10.1634/theoncologist.2013-0065openalex-snapshot
Trastuzumab-Related Cardiotoxicity in Early Breast Cancer: A Cohort Study
inferred← citeshttps://doi.org/10.1634/theoncologist.2015-0230openalex-snapshot
Cardiotoxicity and Cardiac Monitoring During Adjuvant Trastuzumab in Daily Dutch Practice: A Study of the Southeast Netherlands Breast Cancer Consortium
inferred← citeshttps://doi.org/10.18632/oncotarget.17808openalex-snapshot
Association between obesity and trastuzumab-related cardiac toxicity in elderly patients with breast cancer
inferred← citeshttps://doi.org/10.21203/rs.3.rs-3107172/v1openalex-snapshot
Adherence to multidisciplinary team meeting recommendations in elderly patients with HER2-positive breast cancer
inferred← citeshttps://doi.org/10.2147/bctt.s6070openalex-snapshot
Role of trastuzumab in the management of HER2-positive metastatic breast cancer
inferred← citeshttps://doi.org/10.2217/thy.10.65openalex-snapshot
Trastuzumab in the adjuvant setting: a practical review
inferred← citeshttps://doi.org/10.22517/25395203.8919openalex-snapshot
HER-2: Un marcador molecular usado en el diagnóstico, pronóstico y tratamiento del cáncer de mama
inferred← citeshttps://doi.org/10.25011/cim.v42i1.32385openalex-snapshot
Cardio-Oncology: A Tale of Two Cities The art of preventing broken hearts in women with breast cancer
inferred← citeshttps://doi.org/10.3389/conf.fbioe.2016.01.02934openalex-snapshot
High-throughput analysis of kinase inhibitor drugs on cardiac function using engineered heart tissue constructs
inferred← citeshttps://doi.org/10.3389/fonc.2021.744609openalex-snapshot
Adapted Physical Activity for Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Trastuzumab Against HER2 (APACAN2): A Protocol for a Feasibility Study
inferred← citeshttps://doi.org/10.3816/cbc.2008.s.012openalex-snapshot
Current Paradigms for the Use of HER2-Targeted Therapy in Early-Stage Breast Cancer
inferred← citeshttps://doi.org/10.4103/0253-7613.91887openalex-snapshot
Dilated cardiomyopathy following trastuzumab chemotherapy
inferred← citeshttps://doi.org/10.4143/crt.2018.262openalex-snapshot
Early Decline in Left Ventricular Ejection Fraction Can Predict Trastuzumab-Related Cardiotoxicity in Patients with Breast Cancer: A Study Using 13 Years of Registry Data
inferred← citeshttps://doi.org/10.5114/aoms.2012.28549openalex-snapshot
Cardiac complications associated with trastuzumab in the setting of adjuvant chemotherapy for breast cancer overexpressing human epidermal growth factor receptor type 2 – a prospective study
inferred← citeshttps://doi.org/10.5152/akd.2014.5220openalex-snapshot
Echocardiographic signs of right ventricle changes after Trastuzumab treatment in breast cancer patients with erb-2 overexpression
inferred← citeshttps://doi.org/10.5580/29openalex-snapshot
A Comparison between High Frequency Positive Pressure Ventilation and Intermittent Positive Pressure Ventilation during Closed Mitral Valvotomy
inferred← citeshttps://doi.org/10.5603/kp.2014.0126openalex-snapshot
Role of echocardiography in monitoring of cardiac toxicity of cancer pharmacotherapy. Expert consensus statement of the Polish Clinical Forum for Cardiovascular Imaging
inferred← citeshttps://doi.org/10.70675/3945b9d7zaa7cz45e6z9bcbz9fd15d295806openalex-snapshot
Modifications métaboliques induites par la prise en charge thérapeutique des patientes atteintes d'un cancer du sein
inferred← citeshttps://doi.org/10.70675/5725750ez6dbaz45c1zb968za937251229eeopenalex-snapshot
Étude du risque de cardiotoxicité radio-induite précoce chez des patientes traitées par radiothérapie pour un cancer du sein à partir de la cohorte prospective BACCARAT
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.